Ventricular Assistance Devices Global Market-Forecast to 2023

Publishing Date : June, 2017
Report Code : HCMD0147
Price:
Single license $4,950
Site license $6,750
Global license $9,000


The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The ventricular assist devices (VAD) are used to treat end stage heart failure. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body.


Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR).


This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report.

The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment.

Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.

The Ventricular assist devicesis expected to grow at a strong CAGR during 2016 to 2023. Increasing incidences of cardiovascular diseases due to change in lifestyle, shortage of donor heart, Rise in the number of heart failure, shortage of donor heart, increasing ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the ventricular assist devices global market. Many entry level barriers, stringent regulations, high cost of the device, adverse events due to VAD implant and lack of skilled and trained professionals are some of the factors hampering the growth of Ventricular assist devices market.

The ventricular assist devices global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others

• Europe
o Germany
o France
o U.K.
o Others

• Asia-Pacific
o Japan
o China
o India
o Others

• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and others

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE INCIDENCE OF HEART FAILURE
        • 3.3.1.2     SHORTAGE OF HEART DONORS
        • 3.3.1.3     TECHNOLOGICAL ADVANCEMENTS IN VAD
        • 3.3.1.4     RISING GERIATRIC POPULATION
        • 3.3.1.5     VAST PIPELINE PRODUCTS
        • 3.3.1.6     EXPANSION OF LVAD CENTRES IN EMERGING COUNTRIES
        • 3.3.1.7     NEW PRODUCT LAUNCHES
        • 3.3.1.8     INCREASE IN FUNDING FOR LVAD RESEARCH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ADVERSE EVENTS AND COMPLICATION WITH THE IMPLANTATIONS OF VAD
        • 3.3.2.2     COST OF THE DEVICES
        • 3.3.2.3     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.4     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.5     AVAILABILITY OF ALTERNATIVE PRODUCTS
        • 3.3.2.6     REIMBURSEMENT ISSUES IN EMERGING COUNTRIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     JAPAN
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
        • 3.5.1.1     VENTRICULAR ASSIST DEVICE REIMBURSEMENT
        • 3.5.1.2     VAD PHYSICIAN REIMBURSEMENT
    • 3.6     CLINICL TRIAL DATA
    • 3.7     PATENT TRENDS
    • 3.8     TECHNOLOGICAL ADVANCEMENTS
      • 3.8.1     INTRODUCTION
      • 3.8.2     WIRELESS HEART PUMP
      • 3.8.3     MINIATURIZATION OF IMPLANTABLE VENTRICULAR ASSIST DEVICES
      • 3.8.4     VAD APPLICATION
      • 3.8.5     SUPPORTING TOOLS FOR LVAD IMPLANTATION
      • 3.8.6     PERCUTANEOUS VENTRICULAR ASSIST DEVICES
    • 3.9     PORTER’S FIVE FORCE ANALYSIS
      • 3.9.1     THREAT OF NEW ENTRANTS
      • 3.9.2     THREAT OF SUBSTITUTES
      • 3.9.3     BARGAINING POWER OF SUPPLIERS
      • 3.9.4     BARGAINING POWER OF BUYERS
      • 3.9.5     COMPETITIVE RIVALRY
    • 3.10     SUPPLY CHAIN ANALYSIS
    • 3.11     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.12     VENTRICULAR ASSIST DEVICES NUMBER OF UNITS, BY REGION
      • 3.12.1     EXTRACORPOREAL VENTRICULAR ASSIST DEVICES
      • 3.12.2     INTRACORPOREAL VENTRICULAR ASSIST DEVICES
      • 3.12.3     PERCUTANEOUS VENTRICULAR ASSIST DEVICES
    • 3.13     COMPARISON OF VENTRICULAR ASSIST DEVICES
  • 4     VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     LEFT VENTRICULAR ASSIST DEVICES (LVAD)
    • 4.3     RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
    • 4.4     BI-VENTRICULAR ASSIST DEVICES (BIVAD)
  • 5     VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE
    • 5.1     INTRODUCTION
    • 5.2     EXTRACORPOREAL VAD
    • 5.3     INTRACORPOREAL VAD
    • 5.4     PERCUTANEOUS VAD
  • 6     VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE
    • 6.1     INTRODUCTION
    • 6.2     PULSATILE FLOW PUMP
    • 6.3     CONTINUOUS FLOW PUMP
      • 6.3.1     CENTRIFUGAL FLOW PUMP
      • 6.3.2     AXIAL FLOW PUMP
  • 7     VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE
    • 7.1     INTRODUCTION
    • 7.2     PEDIATRIC VAD
    • 7.3     ADULT VAD
  • 8     VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY APPLICATION
    • 8.1     INTRODUCTION
    • 8.2     BRIDGE TO TRANSPLANT (BTT)
    • 8.3     BRIDGE TO DESTINATION THERAPY (BTD)
    • 8.4     BRIDGE TO RECOVERY (BTR)
  • 9     REGIONAL ANALYSIS
    • 9.1     INTRODUCTION
    • 9.2     NORTH AMERICA
      • 9.2.1     U.S.
      • 9.2.2     OTHERS
    • 9.3     EUROPE
      • 9.3.1     GERMANY
      • 9.3.2     FRANCE
      • 9.3.3     U.K.
      • 9.3.4     OTHERS
    • 9.4     APAC
      • 9.4.1     JAPAN
      • 9.4.2     CHINA
      • 9.4.3     INDIA
      • 9.4.4     OTHERS
    • 9.5     ROW
      • 9.5.1     BRAZIL
      • 9.5.2     REST OF LATIN AMERICA
      • 9.5.3     MIDDLE EAST AND OTHERS
  • 10     COMPANY DEVELOPMENTS
    • 10.1     INTRODUCTION
    • 10.2     APPROVALS
    • 10.3     ACQUISITIONS
    • 10.4     PARTNERSHIPS
    • 10.5     OTHER DEVELOPMENTS
  • 11     MAJOR COMPANIES
    • 11.1     ABBOTT LABORATORIES
      • 11.1.1     OVERVIEW
      • 11.1.2     FINANCIALS
      • 11.1.3     PRODUCT PORTFOLIO
      • 11.1.4     KEY DEVELOPMENTS
      • 11.1.5     BUSINESS STRATEGY
      • 11.1.6     SWOT ANALYSIS
    • 11.2     ABIOMED, INC.
      • 11.2.1     OVERVIEW
      • 11.2.2     FINANCIALS
      • 11.2.3     PRODUCT PORTFOLIO
      • 11.2.4     KEY DEVELOPMENTS
      • 11.2.5     BUSINESS STRATEGY
      • 11.2.6     SWOT ANALYSIS
    • 11.3     BERLIN HEART GMBH
      • 11.3.1     OVERVIEW
      • 11.3.2     FINANCIALS
      • 11.3.3     PRODUCT PORTFOLIO
      • 11.3.4     KEY DEVELOPMENTS
      • 11.3.5     BUSINESS STRATEGY
      • 11.3.6     SWOT ANALYSIS
    • 11.4     EVAHEART, INC.
      • 11.4.1     OVERVIEW
      • 11.4.2     FINANCIALS
      • 11.4.3     PRODUCT PORTFOLIO
      • 11.4.4     KEY DEVELOPMENTS
      • 11.4.5     BUSINESS STRATEGY
      • 11.4.6     SWOT ANALYSIS
    • 11.5     FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
      • 11.5.1     OVERVIEW
      • 11.5.2     FINANCIALS
      • 11.5.3     PRODUCT PORTFOLIO
      • 11.5.4     KEY DEVELOPMNTS
      • 11.5.5     BUSINESS STRATEGY
      • 11.5.6     SWOT ANALYSIS
    • 11.6     JARVIK HEART INC.
      • 11.6.1     OVERVIEW
      • 11.6.2     FINANCIALS
      • 11.6.3     PRODUCT PORTFOLIO
      • 11.6.4     KEY DEVELOPMNTS
      • 11.6.5     BUSINESS STRATEGY
      • 11.6.6     SWOT ANALYSIS
    • 11.7     MEDTRONIC PLC
      • 11.7.1     OVERVIEW
      • 11.7.2     FINANCIALS
      • 11.7.3     PRODUCT PORTFOLIO
      • 11.7.4     KEY DEVELOPMENTS
      • 11.7.5     BUSINESS STRATEGY
      • 11.7.6     SWOT ANALYSIS
    • 11.8     RELIANTHEART INC.
      • 11.8.1     OVERVIEW
      • 11.8.2     FINANCIALS
      • 11.8.3     PRODUCT PORTFOLIO
      • 11.8.4     KEY DEVELOPMNTS
      • 11.8.5     BUSINESS STRATEGY
      • 11.8.6     SWOT ANALYSIS
    • 11.9     TANDEMLIFE
      • 11.9.1     OVERVIEW
      • 11.9.2     FINANCIALS
      • 11.9.3     PRODUCT PORTFOLIO
      • 11.9.4     KEY DEVELOPMNTS
      • 11.9.5     BUSINESS STRATEGY
      • 11.9.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
      • TABLE 2     EXTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
      • TABLE 3     INTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
      • TABLE 4     PERCUTANEOUS VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
      • TABLE 5     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 6     LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 7     RIGHT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 8     BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 9     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
      • TABLE 10     EXTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 11     INTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 12     PERCUTANEOUS VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 13     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 14     PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 15     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 16     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 17     CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 18     AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 19     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
      • TABLE 20     PEDIATRIC VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 21     ADULT VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 22     VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 23     BRIDGE TO TRANSPLANT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 24     BRIDGE TO DESTINATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 25     BRIDGE TO RECOVERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 26     VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
      • TABLE 27     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 28     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
      • TABLE 29     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 30     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
      • TABLE 31     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 32     NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 33     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 34     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
      • TABLE 35     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 36     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
      • TABLE 37     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 38     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 39     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 40     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
      • TABLE 41     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 42     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
      • TABLE 43     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 44     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 45     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 46     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
      • TABLE 47     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
      • TABLE 48     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
      • TABLE 49     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 50     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 51     APPROVALS, (2015-2017)
      • TABLE 52     ACQUISITIONS (2015-2017)
      • TABLE 53     PARTNERSHIPS (2015-2017)
      • TABLE 54     OTHER DEVELOPMENTS (2015-2017)
      • TABLE 55     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 56     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
      • TABLE 57     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 58     ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 59     ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 60     FRESENIUS MEDICAL CARE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 61     FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 62     FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 63     MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 64     MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 65     MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 66     MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: VENTRICULAR ASSIST DEVICES GLOBAL MARKET
      • FIGURE 3     VENTRICULAR ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     VENTRICULAR ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     VENTRICULAR ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     VENTRICULAR ASSIST DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     VENTRICULAR ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 9     VENTRICULAR ASSIST DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     VENTRICULAR ASSIST DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     VENTRICULAR ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 12     EXTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
      • FIGURE 13     INTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
      • FIGURE 14     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 15     LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 16     RIGHT VENTRICUALR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION (2016 V/S 2023) (%)
      • FIGURE 17     BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 18     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 19     EXTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 20     INTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 21     PERCUTANEOUS VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 22     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE (2016 V/S 2023) ($MN)
      • FIGURE 23     PULSATILE FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 24     CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 25     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 26     PEDIATRIC VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 27     ADULT VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 28     VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 29     BRIDGE TO TRANSPLANT GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 30     BRIDGE TO DESTINATION THERAPY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 31     BRIDGE TO RECOVERY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 32     VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
      • FIGURE 33     NORTH AMERICA VENTRICULAR ASSIST DEVICES REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 34     NORTH AMERICA VENTRICULAR ASSIST DEVICESREVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 35     U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 36     U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 37     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 38     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 39     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 40     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 41     GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 42     GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 43     FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 44     FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 45     U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 46     U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 47     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 48     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 49     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 50     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 51     JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 52     JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 53     CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 54     CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 55     INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 56     INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 57     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 58     OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 59     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 60     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 61     BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 62     BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 63     REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 64     REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 65     MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 66     MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
      • FIGURE 67     KEY GROWTH STRATEGIES, (2015-2017)
      • FIGURE 68     SWOT: ABBOTT LABORATORIES
      • FIGURE 69     SWOT: ABIOMED
      • FIGURE 70     SWOT: BERLIN HEART GMBH
      • FIGURE 71     SWOT: EVAHEART INC.
      • FIGURE 72     SWOT: FRESENIUS MEDICAL CARE (XENIOS AG)
      • FIGURE 73     SWOT: JARVIK HEART, INC.
      • FIGURE 74     SWOT: MEDTRONIC
      • FIGURE 75     SWOT: RELIANTHEART, INC.
      • FIGURE 76     SWOT: TANDEMLIFE

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ABIOMED , INC.
      • 3     BERLIN HEART GMBH
      • 4     CALON CARDIO -TECHNOLOGY LTD
      • 5     CLEVELAND HEART, INC.
      • 6     CORWAVE
      • 7     EVAHEART, INC.
      • 8     FINEHEART SARL
      • 9     FRESENIUS MEDICAL CARE & CO. KGAA
      • 10     JARVIK HEART
      • 11     MEDTRONIC PLC
      • 12     MITIHEART CORPORATION
      • 13     PROCYRION
      • 14     RELIANT HEART
      • 15     TANDEMLIFE
      • 16     WINDMILL CARDIOVASCULAR SYSTEMS, INC.